Philippe Gevaert (0000-0002-1629-8468)

Personal information

Biography

Prof. Dr. Philippe Gevaert (MD, PhD) is full professor in Rhinology and Allergy at the Department of Otorhinolaryngology. He is the scientific coordinator of the Allergy Network of the Ghent University Hospital and his clinical and research activities are focused on allergic rhinitis and chronic rhinosinusitis with and without nasal polyps.
Since 1998 he is active in the Upper Airway Research Laboratory at the University of Ghent (Prof Dr Paul Van Cauwenberge and Prof Dr Claus Bachert). In 2001 he was working at the Department of Clinical Immunology, Karolinska Hospital in Stockholm, Sweden (Prof Dr SGO Johansson). His research was focused on local IgE expression and eosinophilic inflammation in allergic rhinitis and chronic rhinosinusitis with and without nasal polyps. In 2004 he passed his PhD thesis on “Eosinophilic inflammation in nasal polyposis: Regulation of interleukin 5 and interleukin 5 receptor α isoforms”. Currently, his research is focused on local IgE, allergen specific immunotherapy and biologicals in allergic rhinitis and nasal polyps. He has conducted several academic and industry sponsored clinical trials with novel treatments in nasal polyps and allergic rhinitis. He has published over 200 peer-reviewed papers. He received 9 international research awards. He was recognised by Clarivate as a Highly cited researcher 2023 and 2024.
He was EAACI Junior Member (JMA) Chair in 2003-2005, EAACI interest group “Infection and Allergy” Chair in 2009 - 2011 and EAACI ENT section Chair in 2017-2019

Activities

Collapse all

Ghent University: Ghent, BE

2008-10-01 to present | Professor (Otorhinolaryngology)

Employment

Philippe Gevaert

https://orcid.org/0000-0002-1629-8468

Personal information

Emails & domains

Verified email domains

Keywords

Countries

Biography

Activities

Employment (2)

Ghent University: Ghent, BE

Ghent University Hospital: Ghent, BE

Education and qualifications (4)

Ghent University Hospital: Ghent, BE

Ghent University: Ghent, BE

Ghent University: Ghent, BE

Ghent University: Ghent, BE

Works (50 of 162)

Otitis Media With Effusion (OME) and Eustachian Tube Dysfunction: The Role of Allergy and Immunity—An EAACI Position Paper

Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis

Obituary: Professor Peter Valentin Tomazic, Graz, Austria

EUFOREUM Berlin 2023: Optimizing care for type 2 inflammatory diseases from clinic to AI: A pediatric focus

The multi-omics single-cell landscape of sinus mucosa in uncontrolled severe chronic rhinosinusitis with nasal polyps.

European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis

Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polyps

Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps : a randomized, placebo-controlled trial

Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study

Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps

Phase 3b randomized controlled trial of fevipiprant in patients with nasal polyposis with asthma (THUNDER)

Reboot surgery for chronic rhinosinusitis with nasal polyposis: recurrence and smell kinetics

Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory Studies

The role of IgE in upper and lower airway disease : more than just allergy!

The roles of eosinophils and interleukin‐5 in the pathophysiology of chronic rhinosinusitis with nasal polyps

COVID‐19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies

A 300 IR sublingual tablet is an effective, safe treatment for house dust mite induced allergic rhinitis : an international, double-blind, placebo-controlled, randomized phase III clinical trial

ARIA digital anamorphosis : digital transformation of health and care in airway diseases from research to practice

Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma

Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNP

Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps : a systematic review for the EAACI guidelines

EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics : definitions and management

Indirect treatment comparison of biologics in chronic rhinosinusitis with nasal polyps

Mepolizumab for chronic rhinosinusitis with nasal polyps

Novel antibody cocktail targeting Bet v 1 rapidly and sustainably treats birch allergy symptoms in a Phase 1 study

Omalizumab or dupilumab for chronic rhinosinusitis with nasal polyposis Reply

Pathophysiological and clinical aspects of chronic rhinosinusitis : current concepts

Surgery in nasal polyp patients : outcome after a minimum observation of 10 years

COVID-19 vaccination with BNT162b2 and ChAdOx1 vaccines induces nasal neutralizing antibodies

Management of patients with chronic rhinosinusitis during the COVID‐19 pandemic—An EAACI position paper

Allergic respiratory disease care in the COVID-19 era : a EUFOREA statement

Clinical research needs for the management of chronic rhinosinusitis with nasal polyps in the new era of biologics : a National Institute of Allergy and Infectious Diseases workshop

Efficacy and safety of omalizumab in nasal polyposis : 2 randomized phase 3 trials

European position paper on rhinosinusitis and nasal polyps 2020

Molecular profiling of allergen-specific antibody responses may enhance success of specific immunotherapy

Monoclonal antibodies and airway diseases

Real-life assessment of chronic rhinosinusitis patients using mobile technology : the mySinusitisCoach project by EUFOREA

ARIA masterclass 2018 : from guidelines to real-life implementation

Prioritizing research challenges and funding for allergy and asthma and the need for translational research : the European Strategic Forum on Allergic Diseases

Severe asthma : entering an era of new concepts and emerging therapies : highlights of the 4th International Severe Asthma Forum, Madrid, 2018

Severe spontaneous epistaxis : retrospective study in a tertiary ENT centre

Twelve-year follow-up study after endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyposis

A prospective, feasibility study to evaluate the efficacy and usability of a novel drivable endoscope in patients with chronic rhinosinusitis

Much ado about Biologicals: Highlights of the Master Class on Biologicals, Prague, 2018

EAACI Position paper on the standardization of nasal allergen challenges

FcεRI expression and IgE binding by dendritic cells and basophils in allergic rhinitis and upon allergen immunotherapy.

mySinusitisCoach: patient empowerment in chronic rhinosinusitis using mobile technology.

Prospective study on the outcome of the sphenoid drill out procedure.

Development and validation of a standardized double-blind, placebo-controlled food challenge matrix for raw hazelnuts.

Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32.

Peer review (13 reviews for 2 publications/grants)